The minimal clinically important difference for the patient activation measure in a culturally and linguistically diverse cohort with chronic conditions
Open Access
- 1 March 2026
- journal article
- research article
- Published by Springer Nature in Quality of Life Research
- Vol. 35 (4) , 88
Abstract
Purpose: To estimate the Minimally Clinically Important Difference (MCID) for the Patient Activation Measure (PAM) in a culturally diverse sample of people with chronic disease. Methods: This study was embedded in a larger cluster randomised trial exploring chronic disease management interventions in a culturally diverse sample of 254 adults. Patients were consecutively recruited across 16 outpatient clinics in Sydney, Australia and completed a range of outcomes related to the trial, including the Patient Activation Measure at recruitment and 6 months later. For the current study, the MCID for the PAM was estimated using two distribution methods and four anchor-based methods: mean change difference, and from the receiver operating characteristic curve, the Euclidean and Farra methods, and the Youden Index. A modified self-reported global impression of change, aligned to key elements of the PAM, was used as the external criterion and scores were dichotomised into ‘improved’ and ‘not improved.’ Therefore, the results are likely to overestimate the MCID. Results: 228 participants completed pre- and post-assessments; 51% in the improved group and 49% in the not improved group. Anchor-based methods produced MCIDs between 4 and 7.9, with a value of 4.7 from the preferred Youden method. Distribution-based methods produced MCIDs ranging from 0.26 (standardised effect size) to 5.88 PAM points. Conclusion: Different methods of calculating the PAM for MCID provided different results. Using the preferred Youden Index method, an MCID of 4.7 PAM points was identified as clinically meaningful in this culturally diverse chronic disease cohort. Wider estimates from other anchor-based methods (4.0 to 7.9) are reported to illustrate methodological variability. Trial registration: Study data were collected during a two-phase hybrid cluster randomised controlled trial, approved by the South Western Sydney Local Health District Human Research Ethics Committee (2021/ETH12279) and registered prospectively on the Australian and New Zealand Clinical Trials Registry (ACTRN12622000697785).Keywords
Funding Information
- University of Sydney
This publication has 48 references indexed in Scilit:
- Why Does Patient Activation Matter? An Examination of the Relationships Between Patient Activation and Health-Related OutcomesJournal of General Internal Medicine, 2011
- Is Patient Activation Associated With Future Health Outcomes and Healthcare Utilization Among Patients With Diabetes?Journal of Ambulatory Care Management, 2009
- Measuring self-management of patients’ and employees’ health: Further validation of the Patient Activation Measure (PAM) based on its relation to employee characteristicsPatient Education and Counseling, 2009
- Is Patient Activation Associated With Outcomes of Care for Adults With Chronic Conditions?Journal of Ambulatory Care Management, 2007
- Assessing Activation Stage and Employing a “Next Steps” Approach to Supporting Patient Self-ManagementJournal of Ambulatory Care Management, 2007
- Understanding receiver operating characteristic (ROC) curvesCanadian Journal of Emergency Medicine, 2006
- Development and Testing of a Short Form of the Patient Activation MeasureHealth Services Research, 2005
- Development of the Patient Activation Measure (PAM): Conceptualizing and Measuring Activation in Patients and ConsumersHealth Services Research, 2004
- Glossary of terms relating to ethnicity and race: for reflection and debateJournal of Epidemiology and Community Health, 2004
- Construction of a single global scale for multi‐item assessments of the same variableStatistics in Medicine, 2001